喘可治注射液治疗支气管哮喘疗效观察

Curative effect observation of Chuankezhi injection in the treatment of bronchial asthma

目的探讨喘可治注射液治疗支气管哮喘临床疗效。方法 56例支气管哮喘患者按随机数字表法随机分为治疗组和对照组,各28例。对照组采用常规治疗,治疗组在此基础上采用喘可治注射液雾化吸入,两组均治疗14 d,观察疗效。结果治疗组总有效率为96.4%,对照组总有效率为82.1%,治疗组疗效及肺功能改善均优于对照组,差异具有统计学意义(P<0.05)。结论雾化吸入喘可治注射液治疗支气管哮喘疗效确切,安全可靠,值得推广应用。

Objective To investigate the clinical effect of Chuankezhi injection in the treatment of bronchial asthma. Methods There were 56 patients with bronchial asthma randomly divided into treatment group and control group with 28 cases in each group. Control group was treated by conventional treatment, and treatment group received Chuankezhi injection through aerosol inhalation. Two groups were treated for 14 days and their curative effects were observed. Results The total effective rate of the treatment group was 96.4%, while that of the control group was 82.1%. The curative effect and lung function improvement of the treatment group were better than those of the control group, and the difference had statistical significance （P〈0.05）. Conclusion Aerosol inhalation of Chuankezhi injection in the treatment of bronchial asthma is effective, safe and reliable. It is worth being widely promoted and applied.